Cargando…
The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
BACKGROUND: Many studies have found that YKL-40 may play an important pathogenic role in COPD. However, the results of these studies were inconsistent. Therefore, we performed a systematic review and meta-analysis to investigate the role of YKL-40 in COPD. METHODS: We performed a systematic literatu...
Autores principales: | Tong, Xiang, Wang, Dongguang, Liu, Sitong, Ma, Yao, Li, Zhenzhen, Tian, Panwen, Fan, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796800/ https://www.ncbi.nlm.nih.gov/pubmed/29430175 http://dx.doi.org/10.2147/COPD.S152655 |
Ejemplares similares
-
Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis
por: Tong, Xiang, et al.
Publicado: (2021) -
YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease
por: Mavroudis, Ioannis, et al.
Publicado: (2021) -
YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009) -
Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD
por: Wang, Jing, et al.
Publicado: (2018) -
Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)